The highs — and lows — of JPM 2024 you should pay attention to
In honor of JPM Week, you’re reading a special edition of our biotech newsletter, The…
Category: finance
STAT+: Heated lawsuit between AdventHealth, MultiPlan attracts hospital lobbyists
A lawsuit between a large hospital system and a dominant vendor that works for health…
JPM Day 2 has arrived. Here are the can’t-miss moments of the event so far
In honor of JPM Week, you’re reading a special edition of our biotech newsletter, The…
STAT+: Hospitals try a new pitch to investors: other ways of making money
SAN FRANCISCO — If you learned anything about nonprofit hospitals on the first day of…
UnitedHealth’s next physician acquisition & the January health insurance churn
You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow of money…
STAT+: CVS Health sees Medicare Advantage patients seek more care, eating into profits
Medicare Advantage members continue to go to the doctor and get health care procedures a…
STAT+: At JPM, biotech’s most prolific dealmaker sees a rosy 2024 for acquisitions
SAN FRANCISCO — Eric Tokat, biotech’s most prolific dealmaker, believes 2024 will be another strong…
STAT+: What to expect from hospitals and health insurers at this year’s JPM Healthcare Conference
Nonprofit hospitals often get overshadowed at the J.P. Morgan Healthcare Conference, the health care industry’s…
Anavex’s slow journey to failure
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Goldman Sachs launches $650 million fund for life science investments
Investment bank Goldman Sachs is jumping into the biotech world after raising $650 million to…
STAT+: LabCentral, a crucial incubator for local drug discovery, is slated to grow amid industry slowdown
CAMBRIDGE — Vietnamese-born entrepreneur Jean Pham is “graduating” from LabCentral, a biotech launchpad on the…
STAT+: Here’s who’s profiting the most in health care
For all the flack they get, the country’s four biggest pharmacy benefit managers reported a…
STAT+: 3 medtech trends to watch in 2024
It’s been a slow year for medtech. Major deals in 2023 were scarce, funding was…
Morning Rounds: Our newsroom’s favorite stories of 2023
Understand how science, health policy, and medicine shape the world everyday. Sign up for our…
Morning Rounds: Why health care costs are nearly a fifth of the GDP
Understand how science, health policy, and medicine shape the world everyday. Sign up for our…
BioMarin appeases an activist
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Morning Rounds: Americans put faith in nurses as overall confidence in health care ebbs
Understand how science, health policy, and medicine shape the world everyday. Sign up for our…
.jpg)
The biotech updates you need to read today
Want to stay on top of the science and politics driving biotech today? Sign up to get…
The legal pathway for experimental, ultra-rare disease treatments is rocky and expensive
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: The biggest health care deals of 2023
Every year, the health care industry behaves more and more like a balloon: Squeeze one…
FDA chastens pet companies over antibiotics
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Is it time to worry about Moderna?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: With big ambition — and a family name to match — Reed Jobs charts his own course in biotech
In the months after his father died of complications from pancreatic cancer, Reed Jobs found…
The biotech news you missed from the weekend
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Eli Lilly’s latest $1.4 billion deal might come unglued
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Stephen Hemsley, UnitedHealth Group board chair, sells nearly $113 million in stock
Stephen Hemsley, the board chair and former CEO of UnitedHealth Group, has sold nearly $113…
Why Cerevel Therapeutics has risen 50% in three days without changing anything
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: CVS’s new drug payment plan won’t lower patients’ prices, experts warn
CVS Health is promising to simplify how its pharmacies get paid for drugs. But that…
Novartis is building a new radioligand plant in China
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Do GLP-1s have a future treating alcoholism?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Critics say HCA’s cost-cutting is endangering Appalachian patients — a warning for the whole U.S. health care system
ASHEVILLE, N.C. — There was the beeping of monitors, the stiff sheets, the sterile smell…
STAT+: Cigna, Humana in talks to merge into health insurance giant, per report
Cigna and Humana are in discussions to merge, a potential move that would create a…
Flagship Pioneering crosses the pond, opens a European front
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Saudi VC loops Novo Nordisk, other biotech VCs into new longevity incubator
The Hevolution Foundation, a Saudi investment firm focused on aging science, said Wednesday that it…
A new algorithm unveils CRISPR ‘treasure trove’
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Antitrust lawsuit alleges UnitedHealth’s Optum pressured a California hospital to stop competing over physicians
UnitedHealth Group’s Optum division is already the largest employer of physicians in the United States,…
STAT+: U.S. Anesthesia Partners, Welsh Carson face class action over monopoly allegations
Union health plans that represent electricians and plumbers in Texas have filed a class action…
Bayer’s new CEO was dealt a duo of ‘clearing events.’ Tough choices lie ahead
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: How a major hospital shows just how inflated hospital list prices are
Hospitals’ list prices for surgeries, therapies, and other procedures always come with massive discounts. Financial…
The return of biotech’s “bump factor” amid an economic downturn
Want to stay on top of the science and politics driving biotech today? Sign up to get…
The apparently strong correlation between biotech stocks and the price of eggs, explained
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Is there a bigger move being planned at Cigna?
You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow of money…
Novo Nordisk has its sights on becoming a major player in heart disease
Want to stay on top of the science and politics driving biotech today? Sign up to get…
The first vaccine for the increasingly prevalent chikungunya virus is here
Want to stay on top of the science and politics driving biotech today? Sign up to get…
BioMarin’s new CEO inherits a profitable company, a pioneering gene therapy, and a brewing activist challenge
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Biotech incubator Curie.Bio graduates its first startup
Curie.Bio, the new biotech investment firm and incubator launched earlier this year by a group…
Your morning biotech news roundup
Want to stay on top of the science and politics driving biotech today? Sign up to get…
XBI biotech index rises, giving investors a shred of hope
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Shrinking COVID vaccine sales has Moderna course-correcting
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Novo Nordisk is concluding research on Wegovy’s impact on osteoarthritis
Want to stay on top of the science and politics driving biotech today? Sign up to get…